Today the Government has announced changes to guidance in England for people shielding from COVID-19. These changes will be introduced in two stages – from 6 July and 1 August.
We know there has been concern and uncertainty within the MND community about when and how lockdown will begin to ease, safely, for those shielding. Today’s announcement goes some way to addressing those issues but concerns will remain. It is therefore important that the Government follows its announcement on the future of shielding with extremely clear guidance, advice and sufficient resources ensuring people at increased risk of the effects of COVID-19 can continue to protect themselves.
It is also important at this stage that the Government takes into account the ongoing concerns of individuals and organisations as we approach the implementation dates.
Oxford Biodynamics PLC (LON:OBD) was spun out from Oxford University in June 2007 with the aim of translating fundamental scientific advances into a commercialised platform technology and a new generation of biomarkers for cancer, ALS and other diseases.